TrialOncotarget2015

NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.

Anna Martner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.